灯盏细辛注射液合自血光量子疗法治疗糖尿病周围神经病变的临床研究

Clinical Study on Dengzhan Xixin Injection Combined with Photon-autotransfusion Therapy in Treating Diabetic Peripheral Neuropathy

[目的]探讨灯盏细辛注射液合自血光量子疗法治疗糖尿病周围神经病变的临床疗效。[方法]将确诊为2型糖尿病并周围神经病变的61例患者随机分为治疗组(31例)和对照组(30例)。治疗组予以灯盏细辛注射液30-40mL静脉点滴, 1次/d,配合自血光量子治疗,2-3 d 1次;对照组予以654-2 10-20 mg静脉点滴和维生素B1 100 mg、维生素B12 500μg肌肉注射,1次/d。两组均治疗2个疗程(1个月)。观察两组治疗前后临床症状、体征和神经传导速度的变化,疗程结束后评定疗效。[结果]治疗组的临床显效率(58.07%)和总有效率(93.55%)均优于对照组的16.67%与63.34%,两组比较差异有显著性意义(P<0.01);治疗组神经传导速度的改善亦优于对照组(P<0.01)。[结论]灯盏细辛注射液合自血光量子疗法治疗糖尿病周围神经病变安全而有效。

[Objective] To investigate the effect of Dengzhan Xixin Injection (DXI) combined with photon-autotransfusion therapy in treating diabetic peripheral neuropathy (DPN). [ Methods ] Sixty-one cases of DPN were randomized into 2 groups. Group A ( n=31) was given DXI 30 - 40 mL (intravenous drip, qd) and photon-autotransfusion therapy (once every 2-3 days). Group B (n = 30) was treated with anisodamine 10 - 20 mg (intravenous drip, qd) and vitamin B] 100 mg and B12 500 μg (intramuscular injection, qd) . Changes of symptoms and signs and neural conductive velocity were observed to evaluate the curative effect after treatment. [ Results ] The markedly effective rate and total effective rate were 58.07% and 93.55% respectively in group A, which were higher than those in group B (16.67% and 63.34% respectively) , the difference being significant ( P < 0.01) . Neural conductive velocity was increased in group A (P<0.01 compared with group B). [Conclusion] DXI combined with photon-autotransfusion therapy is effective and safe in treating DPN.